Investing.com - Nicox reported on Friday second quarter earnings that matched analysts' forecasts and revenue that fell short of expectations.
Nicox announced earnings per share of €-0.16 on revenue of €700K. Analysts polled by Investing.com anticipated EPS of €-0.16 on revenue of €750K.
Nicox shares are down 26.42% from the beginning of the year , still down 47.99% from its 52 week high of €3.62 set on Friday, September 17, 2021.
Nicox follows other major Healthcare sector earnings this month
Nicox's report follows an earnings missed by Biomerieux on Wednesday, August 31, 2022, who reported EPS of €1.93 on revenue of €820.9M, compared to forecasts EPS of €2.22 on revenue of €719.4M.
Erytech Pharma had beat expectations on Monday with second quarter EPS of €-0.03 on revenue of €25.30M, compared to forecast for EPS of €-0.33 on revenue of €2.5M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar